NASDAQ:IONS - Ionis Pharmaceuticals Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $78.90 -1.60 (-1.99 %) (As of 03/22/2019 04:00 PM ET)Previous Close$78.90Today's Range$78.52 - $80.6052-Week Range$39.07 - $81.03Volume790,899 shsAverage Volume1.39 million shsMarket Capitalization$10.92 billionP/E Ratio26.66Dividend YieldN/ABeta2.4 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Ionis Pharmaceuticals (NASDAQ:IONS) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.7 Wall Street analysts have issued ratings and price targets for Ionis Pharmaceuticals in the last 12 months. Their average twelve-month price target is $61.8571, suggesting that the stock has a possible downside of 21.60%. The high price target for IONS is $82.00 and the low price target for IONS is $48.00. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: HoldHoldHoldHoldConsensus Rating Score: 2.002.002.002.00Ratings Breakdown: 1 Sell Rating(s)5 Hold Rating(s)1 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)4 Hold Rating(s)1 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)5 Hold Rating(s)1 Buy Rating(s)0 Strong Buy Rating(s)2 Sell Rating(s)4 Hold Rating(s)2 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $61.8571$53.50$53.7143$52.00Price Target Upside: 21.60% downside3.50% downside3.11% downside1.60% upsideIonis Pharmaceuticals (NASDAQ:IONS) Consensus Price Target History Ionis Pharmaceuticals (NASDAQ:IONS) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails3/22/2019Piper Jaffray CompaniesBoost Price TargetNeutral$63.00 ➝ $75.00Low3/18/2019JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$47.00 ➝ $55.00Low3/1/2019Morgan StanleySet Price TargetHold$71.00Low2/28/2019BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$70.00 ➝ $82.00Low11/27/2018Leerink SwannInitiated CoverageMarket Perform$50.00High9/25/2018Stifel NicolausBoost Price TargetHold ➝ Hold$45.00 ➝ $48.00High6/20/2018BarclaysDowngradeEqual Weight ➝ Underweight$52.00High2/20/2018Sanford C. BernsteinReiterated RatingMarket Perform$61.00 ➝ $55.00Low10/17/2017Needham & Company LLCReiterated RatingBuy$64.00N/A10/6/2017Goldman Sachs GroupReiterated RatingSell ➝ Sell$30.00N/A8/16/2017Evercore ISIInitiated CoverageOutperform ➝ Outperform$65.00Low8/14/2017LaidlawReiterated RatingBuy$65.00Low8/10/2017Jefferies Financial GroupReiterated RatingUnderperform$17.00 ➝ $18.00High5/22/2017CowenReiterated RatingMarket PerformLow(Data available from 3/23/2017 forward) This page was last updated on 3/23/2019 by MarketBeat.com StaffFeatured Article: Why is a lock-up period needed for an IPO?